Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 47, 2012 - Issue 5
Submit an article Journal homepage
774
Views
42
CrossRef citations to date
0
Altmetric
Liver and Bilary Disease

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

A Barbero-VillaresInstituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitario de La Princesa, Gastroenterology units of the hospitals, Madrid, Spain
,
J Mendoza Jiménez-RidruejoInstituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitario de La Princesa, Gastroenterology units of the hospitals, Madrid, Spain
,
C TaxoneraClínico San Carlos, Gastroenterology units of the hospitals, Madrid, Spain
,
A López-SanrománRamón y Cajal, Gastroenterology units of the hospitals, Madrid, Spain
,
R PajaresLa Paz, Gastroenterology units of the hospitals, Madrid, Spain
,
F BermejoFuenlabrada, Gastroenterology units of the hospitals, Madrid, Spain
,
JL Pérez-CalleAlcorcón, Gastroenterology units of the hospitals, Madrid, Spain
,
JL MendozaClínico San Carlos, Gastroenterology units of the hospitals, Madrid, Spain
,
A AlgabaFuenlabrada, Gastroenterology units of the hospitals, Madrid, Spain
,
R Moreno-OteroInstituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitario de La Princesa, Gastroenterology units of the hospitals, Madrid, Spain
,
J MatéInstituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitario de La Princesa, Gastroenterology units of the hospitals, Madrid, Spain
,
JP GisbertInstituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitario de La Princesa, Gastroenterology units of the hospitals, Madrid, SpainCorrespondence[email protected]
& On behalf of the Madrid Group for the Study of Inflammatory Bowel Disease (ENICMAD) show all
Pages 575-579 | Received 29 Oct 2011, Accepted 02 Dec 2011, Published online: 10 Jan 2012

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Harriet S Cheng & Marius Rademaker. (2018) Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography. Psoriasis: Targets and Therapy 8, pages 21-29.
Read now
Edoardo Troncone & Giovanni Monteleone. (2017) The safety of non-biological treatments in Ulcerative Colitis. Expert Opinion on Drug Safety 16:7, pages 779-789.
Read now
Tommaso Gabbani, Simona Deiana, Sarah Lunardi, Natalia Manetti & Vito Annese. (2016) Safety profile of methotrexate in inflammatory bowel disease. Expert Opinion on Drug Safety 15:10, pages 1427-1437.
Read now

Articles from other publishers (39)

M. Ruiz-Ponce, L. Cuesta-López, M.D. López-Montilla, C. Pérez-Sánchez, P. Ortiz-Buitrago, A. Barranco, M.D. Gahete, N. Herman-Sánchez, A.J. Lucendo, P. Navarro, Ch López-Pedrera, A. Escudero-Contreras, E. Collantes-Estévez, C. López-Medina, I. Arias-de la Rosa & N. Barbarroja. (2023) Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses. Biomedicine & Pharmacotherapy 168, pages 115779.
Crossref
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka & Rafał Filip. (2023) What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 13:3, pages 378.
Crossref
Edmond Atallah, Jane I. Grove, Colin Crooks, Esther Burden-Teh, Abhishek Abhishek, Sulleman Moreea, Kelsey M. Jordan, Aftab Ala, David Hutchinson, Richard J. Aspinall, Ruth Murphy & Guruprasad P. Aithal. (2023) Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. Journal of Hepatology.
Crossref
Esam M. Aboubakr, Ahmed R. N. Ibrahim, Fares E. M. Ali, Ahmed A. E. Mourad, Adel M. Ahmad & Amal Hofni. (2022) Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals. Pharmaceuticals 15:11, pages 1436.
Crossref
Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt & Helmut K. Seitz. (2022) Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. Journal of Clinical Medicine 11:9, pages 2623.
Crossref
Jordina Llaó, Helena Masnou, Cristina Romero, Anna Bargalló, Cristina Gely, Míriam Mañosa, Jordi Gordillo, Esther Garcia-Planella & Eugeni Domènech. (2020) Noninvasive assessment of liver fibrosis in Crohn’s disease patients exposed to methotrexate. European Journal of Gastroenterology & Hepatology 33:6, pages 794-798.
Crossref
Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng & Yang-Yuan Chen. (2021) Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. PLOS ONE 16:5, pages e0252286.
Crossref
Ali Azzam, Zainab Jiyad & James O’Beirne. (2021) Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis. Australasian Journal of Dermatology 62:2, pages 130-140.
Crossref
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo & Mariabeatrice Principi. (2020) Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study. Pathogens 9:11, pages 870.
Crossref
Jean-Paul Cervoni, Blandine Alby-Lepresle, Delphine Weil, Peng Zhong, François Aubin, Daniel Wendling, Eric Toussirot, Lucine Vuitton, Franck Carbonnel, Raphaële Blondet, Thierry Thévenot, Paul Calès, Elisabeth Monnet & Vincent Di Martino. (2020) A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy. Clinics and Research in Hepatology and Gastroenterology 44, pages 100003.
Crossref
Zi-Yuan Zou, Bo Shen & Jian-Gao Fan. (2019) Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 25:11, pages 1764-1772.
Crossref
Salvatore Magrì, Danilo Paduano, Fabio Chicco, Arianna Cingolani, Cristiana Farris, Giovanna Delogu, Francesca Tumbarello, Mariantonia Lai, Alessandro Melis, Laura Casula, Massimo C Fantini & Paolo Usai. (2019) Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World Journal of Gastroenterology 25:37, pages 5676-5686.
Crossref
Haluk Tarik KANI, İlknur DELIKTAS & Yusuf YILMAZ. (2019) Prevalence of fatty liver disease in patients with inflammatory bowel disease: a transient elastography study on the basis of a controlled attenuation parameter. Marmara Medical Journal 32:2, pages 68-70.
Crossref
Jessica G. Labadie & Manish Jain. (2019) Noninvasive Tests to Monitor Methotrexate‐Induced Liver Injury. Clinical Liver Disease 13:3, pages 67-71.
Crossref
Berrie Meijer, Charlotte K. van Everdingen, Dewkoemar Ramsoekh, Catherine Stedman, Christopher M.A. Frampton, Chris J.J. Mulder, Gerd Bouma, Nanne K.H. de Boer & Richard B. Gearry. (2018) Transient elastography to assess liver stiffness in patients with inflammatory bowel disease. Digestive and Liver Disease 50:1, pages 48-53.
Crossref
Marius Rademaker, Monisha Gupta, Megan Andrews, Katherine Armour, Chris Baker, Peter Foley, Kurt Gebauer, Jacob George, Diana Rubel & John Sullivan. (2017) The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting. Australasian Journal of Dermatology 58:3, pages 166-170.
Crossref
Sophie Restellini, Olivier Chazouillères & Jean‐Louis Frossard. (2016) Hepatic manifestations of inflammatory bowel diseases. Liver International 37:4, pages 475-489.
Crossref
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa & Angelo Viscido. (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 49:4, pages 338-358.
Crossref
Gerassimos J. Mantzaris. (2017) Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. Current Treatment Options in Gastroenterology 15:1, pages 84-104.
Crossref
My-Linh Tran-Minh, Paula Sousa, Marianne Maillet, Matthieu Allez & Jean-Marc Gornet. (2017) Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World Journal of Hepatology 9:13, pages 613.
Crossref
Grace Harkin & Laurence Egan. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 333 342 .
Talat Bessissow, Ngoc Han Le, Kathleen Rollet, Waqqas Afif, Alain Bitton & Giada Sebastiani. (2016) Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 22:8, pages 1937-1944.
Crossref
Che-Yung Chao, Robert Battat, Alex Al Khoury, Sophie Restellini, Giada Sebastiani & Talat Bessissow. (2016) Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. World Journal of Gastroenterology 22:34, pages 7727.
Crossref
Benjamin H. Kaffenberger, Jessica A. Kaffenberger, Henry Wong, Wael Jarjour, Douglas Levin & Mark A. Bechtel. (2015) Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?. International Journal of Dermatology 54:7, pages 752-756.
Crossref
Fernando Gomollón, Saioa Rubio, Mara Charro, Santiago García-López, Fernando Muñoz, Javier P. Gisbert & Eugeni Domènech. (2015) Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el uso de metotrexato en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 38:1, pages 24-30.
Crossref
Jin Su Park, Min-Chan Park, Yong-Beom Park, Soo-Kon Lee & Sang-Won Lee. (2014) Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function. Clinical Rheumatology 33:10, pages 1415-1423.
Crossref
L.W.Y. Thin, I.C. Lawrance, K. Spilsbury, J. Kava & J.K. Olynyk. (2014) Detection of liver injury in IBD using transient elastography. Journal of Crohn's and Colitis 8:7, pages 671-677.
Crossref
Hee-Jin Park, Min-Chan Park, Yong-Beom Park, Soo-Kon Lee & Sang-Won Lee. (2013) The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis. Rheumatology International 34:6, pages 833-840.
Crossref
Fernando Bessone. (2014) Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World Journal of Hepatology 6:6, pages 394.
Crossref
María Chaparro & Javier P. Gisbert. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 135 143 .
Imeke Goldschmidt, Henrik Stieghorst, Mona Munteanu, Thierry Poynard, Jerome Schlue, Carolin Streckenbach & Ulrich Baumann. (2013) The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients. Pediatric Transplantation 17:6, pages 525-534.
Crossref
Margien L. Seinen, Cyriel Y. Ponsioen, Nanne K.H. de Boer, Bas Oldenburg, Gerd Bouma, Chris J.J. Mulder & Adriaan A. van Bodegraven. (2013) Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology 11:6, pages 667-672.
Crossref
N. Frulio & H. Trillaud. (2013) Élastographie ultrasonore hépatique. Journal de Radiologie Diagnostique et Interventionnelle 94:5, pages 531-549.
Crossref
N. Frulio & H. Trillaud. (2013) Ultrasound elastography in liver. Diagnostic and Interventional Imaging 94:5, pages 515-534.
Crossref
Chong Meng Yeo. (2013) Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World Journal of Hepatology 5:5, pages 275.
Crossref
Luciano Sanromán Álvarez, María Luisa de Castro Parga, Vicent Hernández Ramírez, Juan Clofent Vilaplana, Juan Ramón Pineda Mariño, José-Antonio Hermo Brión, Lucía Cid Gómez, Alfonso Martínez Turnes, Fulgencio Domínguez Rodriguez, Pamela Estévez Boullosa & José-Ignacio Rodríguez-Prada. (2012) Protocolo para la monitorización de la terapia inmunosupresora y biológica en una unidad de atención integral a pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 35:8, pages 602-607.
Crossref
Yago González-Lama, Carlos Taxonera, Antonio López-Sanromán, José Lázaro Pérez-Calle, Fernando Bermejo, Ramón Pajares, Adrian G. McNicholl, Verónica Opio, Juan Luis Mendoza, Pilar López, Alicia Algaba, Jesús Estelles, Almudena Barbero, Jorge Mendoza, José Maté & Javier P. Gisbert. (2012) Methotrexate in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 24:9, pages 1086-1091.
Crossref
Kyu Sik JungSeung Up Kim. (2012) Clinical applications of transient elastography. Clinical and Molecular Hepatology 18:2, pages 163.
Crossref
Sang-Won Lee, Hee-Jin Park, Beom Kim, Kwang-Hyub Han, Soo-Kon Lee, Seung Kim & Yong-Beom Park. (2012) Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Research & Therapy 14:5, pages R232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.